4//SEC Filing
Lynch Brian Joseph 4
Accession 0000950170-23-067360
CIK 0001157601other
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 4:30 PM ET
Size
18.5 KB
Accession
0000950170-23-067360
Insider Transaction Report
Form 4
Lynch Brian Joseph
SVP and General Counsel
Transactions
- Exercise/Conversion
Common Stock
2023-11-29$73.75/sh+4,000$295,000→ 19,001 total - Sale
Common Stock
2023-11-29$199.45/sh−3,000$598,350→ 15,001 total - Sale
Common Stock
2023-11-30$206.73/sh−1,000$206,730→ 15,001 total - Sale
Common Stock
2023-11-29$198.40/sh−1,000$198,400→ 18,001 total - Exercise/Conversion
Common Stock
2023-11-30$73.75/sh+3,000$221,250→ 18,001 total - Sale
Common Stock
2023-11-30$204.00/sh−1,000$204,000→ 17,001 total - Sale
Common Stock
2023-11-30$203.00/sh−1,000$203,000→ 16,001 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-11-30−3,000→ 18,000 totalExercise: $73.75Exp: 2032-08-10→ Common Stock (3,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2023-11-29−4,000→ 21,000 totalExercise: $73.75Exp: 2032-08-10→ Common Stock (4,000 underlying)
Holdings
- 530(indirect: By IRA)
Common Stock
Footnotes (2)
- [F1]All shares issued pursuant to the exercise of the options reported herein represent 7,000 shares underlying an overall option award of 25,000 shares. All exercised options had vested. As to the overall option for 25,000 shares, 25% of the shares underlying the option vested on August 10, 2023 and, thereafter, 6.25% of the shares vested, or will vest, on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.25 to $199.59, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote
Documents
Issuer
MADRIGAL PHARMACEUTICALS, INC.
CIK 0001157601
Entity typeother
Related Parties
1- filerCIK 0001776196
Filing Metadata
- Form type
- 4
- Filed
- Nov 30, 7:00 PM ET
- Accepted
- Dec 1, 4:30 PM ET
- Size
- 18.5 KB